Category: Providers

2024 340B Contract Pharmacy Outlook: Expect More State Than Federal Action, Say Attorneys and Lobbyists

January 9, 2024 William Newton, Associate Editor/Senior Writer Views

US Eighth Circuit Court of Appeals building

A decision upholding Arkansas' state contract pharmacy law from the U.S. 8th Circuit Court of Appeals could cause more states to push similar laws, attorneys and lobbyists said.

Amid expected congressional gridlock, there is a much higher likelihood of state legislative action on 340B contract pharmacies than federal [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Novo Says Arkansas Agreement ‘Preserves It’s Position’; More Manufacturer Deals in the Works

January 5, 2024 Rich Daly, Editor in Chief Views

Arkansas Insurance Department office sign

The Arkansas Insurance Department will imminently enforce a state 340B contract pharmacy law following a key federal appeals court decision.

Drugmaker Novo Nordisk’s deal with Arkansas restoring 340B discounts in the contract pharmacy setting until a coming appeals court ruling, [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Two 340B Terminations, Two Paybacks to Manufacturers in Latest Provider Audit Findings

January 5, 2024 Rich Daly, Editor in Chief Views

Federal auditors determined terminations from the 340B program were required for either covered entity sites or a contract pharmacy of two more 340B providers.

Federal auditors determined terminations from the 340B program were required for either covered entity sites or a contract pharmacy of [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

2024 Congressional 340B Outlook: Overhaul Unlikely Without Major Legal Developments, Senate Deal

January 5, 2024 William Newton, Associate Editor/Senior Writer Views

A Senate Committee recently approved the FY25 Departments of Labor, Health and Human Services, Education and Related Agencies Appropriations Act.

In 2024, congressional gridlock and election year dynamics will likely slow momentum on any comprehensive 340B program reform package, lobbyists [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

2023 Contract Pharmacy Developments: Surging Restrictions, State Law Legal Battles

January 3, 2024 William Newton, Associate Editor/Senior Writer Views

In 2023, Arkansas became the first state to move to enforce a 340B contract pharmacy law as manufacturer restrictions continued to increase.

In 2023, the battle over the use of contract pharmacy arrangements by 340B providers was marked by increasing drugmaker restrictions, [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Louisiana, Health Centers Seek Dismissal of Contract Pharmacy Law Challenge

December 21, 2023 William Newton, Associate Editor/Senior Writer Views

AstraZeneca will discontinue a certain bottle dosage of its breast cancer drug Truqap (capiversatib) by the end of the year but allow 340B covered entities to replenish their supply with an equivalent dose in blister pack package form.

Attorneys representing the state of Louisiana and 340B providers urged a federal judge to dismiss AstraZeneca’s lawsuit against Louisiana’s contract [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Column: Hospitals Are Not the Only 340B Providers Under Scrutiny

December 21, 2023 Ted Slafsky, Publisher & CEO Views

Ted Slafsky, publisher and CEO of 340B Report, writes the second part of his two-part column on the Senate "group of six" 340B discussion draft.

Veteran 340B observers were surprised to see that Sen. Bill Cassidy (R-La.) has expanded his 340B investigation into community health [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Lilly to Conduct HRSA-Approved Audit That Includes First-Time Look for Medicaid MCO Duplicate Discounts

December 19, 2023 Rich Daly, Editor in Chief Views

Eli Lilly is conducting government approved 340B provider audits that for the first time look for certain Medicaid health plan duplicate discounts.

Federal regulators have approved a first-time 340B provider audit by a drug manufacturer to examine processes to prevent duplicate discounts [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Takeda Becomes 29th Drugmaker to Implement 340B Contract Pharmacy Restrictions

December 18, 2023 William Newton, Associate Editor/Senior Writer Views

Japanese drugmaker Takeda announced its cancer medication Ninlaro will be subject to its 340B contract pharmacy policy.

Japanese pharmaceutical giant Takeda last Friday became the 29th drugmaker to place conditions on 340B pricing in the contract pharmacy [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

HRSA Unveils Web Page with Patient Definition Compliance Resources, Guidance

December 14, 2023 Rich Daly, Editor in Chief Views

HRSA released a new web page with resources on the agency's 340B program patient definition and compliance guidelines.

In the wake of a high-profile federal court ruling casting doubt on the definition of eligible “patient” in the 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Category: Providers

2024 340B Contract Pharmacy Outlook: Expect More State Than Federal Action, Say Attorneys and Lobbyists

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Novo Says Arkansas Agreement ‘Preserves It’s Position’; More Manufacturer Deals in the Works

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Two 340B Terminations, Two Paybacks to Manufacturers in Latest Provider Audit Findings

Please Login or Become a Paid Subscriber to View this Content

If you are already a

2024 Congressional 340B Outlook: Overhaul Unlikely Without Major Legal Developments, Senate Deal

Please Login or Become a Paid Subscriber to View this Content

If you are already a

2023 Contract Pharmacy Developments: Surging Restrictions, State Law Legal Battles

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Louisiana, Health Centers Seek Dismissal of Contract Pharmacy Law Challenge

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Column: Hospitals Are Not the Only 340B Providers Under Scrutiny

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Exclusive

Lilly to Conduct HRSA-Approved Audit That Includes First-Time Look for Medicaid MCO Duplicate Discounts

Please Login or Become a Paid Subscriber to View this Content

If you are already a

News Alert

Takeda Becomes 29th Drugmaker to Implement 340B Contract Pharmacy Restrictions

Please Login or Become a Paid Subscriber to View this Content

If you are already a

News Alert

HRSA Unveils Web Page with Patient Definition Compliance Resources, Guidance

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Exclusive

Please Login or Become a Paid Subscriber to View this Content

If you are already a

News Alert

Please Login or Become a Paid Subscriber to View this Content

If you are already a

News Alert

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Site Footer Live